Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal stem cells derived from peripheral blood protects against ischemia.

Journal of neurotrauma - 1 Mar 2007

Ukai Ryo, Honmou Osamu, Harada Kuniaki, Houkin Kiyohiro, Hamada Hirofumi, Kocsis Jeffery D

Abstract excerpt

Intravenous delivery of mesenchymal stem cells (MSCs) prepared from bone marrow (BMSCs) reduces infarction volume and ameliorates functional deficits in a rat cerebral ischemia model. MSC-like multipotent precursor cells (PMSCs) have also been suggested to exist in peripheral blood. To test the hypothesis that treatment with PMSCs may have a therapeutic benefit in stroke, we compared the efficacy of systemic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Ischemia
Share to Capillaries
Share to Coloring Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exercise Test

Share to Image Processing, Computer-Assisted

Share to Infarction, Middle Cerebral Artery

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 17402856
DOI: 10.1089/neu.2006.0161
PMCID: PMC2605398

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal stem cells derived from peripheral blood protects against ischemia.PMID 17402856Read ↗

Multipotent bone marrow stromal cell therapy promotes endogenous cell proliferation following ischemic stroke.Semantic proximity Read ↗

Homing genes, cell therapy and strokeSemantic proximity Read ↗

Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic StrokeSemantic proximity Read ↗

Clinical Efficacy and Meta‐Analysis of Stem Cell Therapies for Patients with Brain IschemiaSemantic proximity Read ↗

Vascular disease and stem cell therapiesSemantic proximity Read ↗

Preclinical Evaluation of Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb IschemiaSemantic proximity Read ↗

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury.Semantic proximity Read ↗

Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury.Semantic proximity Read ↗

Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury.Semantic proximity Read ↗

Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.Semantic proximity Read ↗

Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct.Semantic proximity Read ↗

Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.